[Ip-health] WHA69 - MSF intervention on CEWG on R&D Financing and Coordination
joanna.l.keenan at gmail.com
Fri May 27 08:50:58 PDT 2016
WHO 69th World Health Assembly: Agenda item 16.2 – the Consultative Expert
Working Group on Research and Development: Financing and Coordination
Speaker: Judit Rius Sanjuan
As Member States continue negotiating the CEWG, it’s important to note that
the warnings and call to action underlined in the report are more relevant
now than ever.
The UN Secretary General’s decision to launch a High Level Panel on Access
to Medicines underlines that the failings of the R&D system affect
everyone. Access to medicines is a global challenge – now a rising
political priority for electorates in the EU, US and every country. This is
a structural problem that cannot be addressed by countries acting alone. It
necessitates global coordination and agreement.
In 2012, the CEWG set a roadmap to reform financing for research and
development to meet the needs of people in developing countries, including
a recommendation for a global agreement to ensure sustainable financing,
prioritisation, coordination. Most importantly, it also established the
norms and principles on how R&D should be financed to ensure innovation and
access. R&D must be needs-driven, evidence-based, de-linked from prices,
and ensure affordability, efficacy, equity – and be a shared
responsibility. Yet in discussions this week, and elsewhere such as at the
G7, we are concerned that the CEWG is being left behind.
MSF hopes that the discussions on the CEWG this week are seen as an
opportunity to start to fix what is broken. Governments should not fragment
discussions on R&D – do not exclude antibiotic resistance and other R&D
priorities from the remit of the CEWG.
We also hope that Member States have ambition. Do not just observe the
failures of the R&D system, act upon them. We urge all governments to
commit to an inter-governmental conference on R&D before the next WHA to
connect the dots and ensure policy coherence. Our broken system of R&D is
a problem that governments have created, and it is something which
ultimately only governments can solve.
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
More information about the Ip-health